These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 29020172)

  • 21. Prevalence of cryptococcal infection among advanced HIV patients in Argentina using lateral flow immunoassay.
    Frola C; Guelfand L; Blugerman G; Szyld E; Kaufman S; Cahn P; Sued O; Pérez H
    PLoS One; 2017; 12(6):e0178721. PubMed ID: 28617817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of Reflex Cryptococcal Antigen (CrAg) Screening in Human Immunodeficiency Virus (HIV)-Positive Patients With CD4 Counts of 100-200 Cells/µL in Botswana.
    Tenforde MW; Milton T; Rulaganyang I; Muthoga C; Tawe L; Chiller T; Greene G; Jordan A; Williams CG; Owen L; Leeme TB; Boose A; Ngidi J; Mine M; Jarvis JN
    Clin Infect Dis; 2021 May; 72(9):1635-1638. PubMed ID: 32604411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986-2012.
    McKenney J; Bauman S; Neary B; Detels R; French A; Margolick J; Doherty B; Klausner JD
    Clin Infect Dis; 2015 Mar; 60(6):959-65. PubMed ID: 25422390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prevalence of cryptococcal antigen (CrAg) and benefits of pre-emptive antifungal treatment among HIV-infected persons with CD4+ T-cell counts < 200 cells/μL: evidence based on a meta-analysis.
    Li Y; Huang X; Chen H; Qin Y; Hou J; Li A; Wu H; Yan X; Chen Y
    BMC Infect Dis; 2020 Jun; 20(1):410. PubMed ID: 32532212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi.
    Nussbaum JC; Jackson A; Namarika D; Phulusa J; Kenala J; Kanyemba C; Jarvis JN; Jaffar S; Hosseinipour MC; Kamwendo D; van der Horst CM; Harrison TS
    Clin Infect Dis; 2010 Feb; 50(3):338-44. PubMed ID: 20038244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum cryptococcal antigen titre as a diagnostic tool and a predictor of mortality in HIV-infected patients with cryptococcal meningitis.
    Chen J; Zhang R; Shen Y; Liu L; Qi T; Wang Z; Mehraj V; Routy JP; Lu H
    HIV Med; 2019 Jan; 20(1):69-73. PubMed ID: 30311440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Point-of-Care Testing for Cryptococcal Disease Among Hospitalized Human Immunodeficiency Virus-Infected Adults in Ethiopia.
    Mamuye AT; Bornstein E; Temesgen O; Blumberg HM; Kempker RR
    Am J Trop Med Hyg; 2016 Oct; 95(4):786-792. PubMed ID: 27527636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cryptococcal Antigenemia in Human Immunodeficiency Virus Antiretroviral Therapy-Experienced Ugandans With Virologic Failure.
    Mpoza E; Rajasingham R; Tugume L; Rhein J; Nabaggala MS; Ssewanyana I; Nyegenye W; Kushemererwa GE; Mulema V; Kalamya J; Kiyaga C; Kabanda J; Ssali M; Boulware DR; Meya DB
    Clin Infect Dis; 2020 Oct; 71(7):1726-1731. PubMed ID: 31679007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Six-month outcomes of HIV-infected patients given short-course fluconazole therapy for asymptomatic cryptococcal antigenemia.
    Kapoor SW; Magambo KA; Kalluvya SE; Fitzgerald DW; Peck RN; Downs JA
    AIDS; 2015 Nov; 29(18):2473-8. PubMed ID: 26372487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preventing deaths from cryptococcal meningitis: from bench to bedside.
    Roy M; Chiller T
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):715-7. PubMed ID: 21905781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A qualitative evaluation of an implementation study for cryptococcal antigen screening and treatment in Uganda.
    Lofgren SM; Nalintya E; Meya DB; Boulware DR; Rajasingham R
    Medicine (Baltimore); 2018 Aug; 97(31):e11722. PubMed ID: 30075580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of single-dose AmBisome pre-emptive treatment for the prevention of cryptococcal meningitis in African low and middle-income countries.
    Rajasingham R; Nalintya E; Israelski DM; Meya DB; Larson BA; Boulware DR
    Med Mycol; 2022 Feb; 60(2):. PubMed ID: 35026017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of experimental cryptococcal meningitis with fluconazole: impact of dose and addition of flucytosine on mycologic and pathophysiologic outcome.
    Kartalija M; Kaye K; Tureen JH; Liu Q; Täuber MG; Elliott BR; Sande MA
    J Infect Dis; 1996 May; 173(5):1216-21. PubMed ID: 8627075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LATERAL FLOW ASSAY FOR CRYPTOCOCCAL ANTIGEN: AN IMPORTANT ADVANCE TO IMPROVE THE CONTINUUM OF HIV CARE AND REDUCE CRYPTOCOCCAL MENINGITIS-RELATED MORTALITY.
    Vidal JE; Boulware DR
    Rev Inst Med Trop Sao Paulo; 2015 Sep; 57 Suppl 19(Suppl 19):38-45. PubMed ID: 26465368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial.
    Parkes-Ratanshi R; Wakeham K; Levin J; Namusoke D; Whitworth J; Coutinho A; Mugisha NK; Grosskurth H; Kamali A; Lalloo DG;
    Lancet Infect Dis; 2011 Dec; 11(12):933-41. PubMed ID: 21982529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High prevalence of cryptococcal infection among HIV-infected patients hospitalized with pneumonia in Thailand.
    Harris JR; Lindsley MD; Henchaichon S; Poonwan N; Naorat S; Prapasiri P; Chantra S; Ruamcharoen F; Chang LS; Chittaganpitch M; Mehta N; Peruski L; Maloney SA; Park BJ; Baggett HC
    Clin Infect Dis; 2012 Mar; 54(5):e43-50. PubMed ID: 22198791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV-associated disseminated cryptococcosis-An unusual clinical and diagnostic picture with successful cure by single dose liposomal amphotericin B treatment.
    Gupta C; Dogra P; Jain V; Kaur R; Sharma JB
    Diagn Microbiol Infect Dis; 2024 Jun; 109(2):116217. PubMed ID: 38513558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cryptococcal infection in HIV-infected patients with CD4
    Pérez-Jacoiste Asín MA; Bisbal O; Iribarren JA; Pérez-Rivilla A; Mican R; Dronda F; González-Domenech CM; Vinuesa-García D; Macías J; Lumbreras C; Moreno S; Rubio R;
    Clin Microbiol Infect; 2021 Aug; 27(8):1171.e1-1171.e7. PubMed ID: 33069858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluconazole monotherapy for cryptococcosis in non-AIDS patients.
    Yamaguchi H; Ikemoto H; Watanabe K; Ito A; Hara K; Kohno S
    Eur J Clin Microbiol Infect Dis; 1996 Oct; 15(10):787-92. PubMed ID: 8950555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurocognitive function in HIV-infected persons with asymptomatic cryptococcal antigenemia: a comparison of three prospective cohorts.
    Montgomery MP; Nakasujja N; Morawski BM; Rajasingham R; Rhein J; Nalintya E; Williams DA; Huppler Hullsiek K; Kiragga A; Rolfes MA; Donahue Carlson R; Bahr NC; Birkenkamp KE; Manabe YC; Bohjanen PR; Kaplan JE; Kambugu A; Meya DB; Boulware DR;
    BMC Neurol; 2017 Jun; 17(1):110. PubMed ID: 28606065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.